Skip to main content

Media

Stay up-to-date with Roche's latest news, events and announcements.

Media events

Never miss out on past and upcoming Roche events

Media statements

Get access to the latest Roche media statements

Subscribe to Roche news

Get the latest news and updates to your inbox

+11%

Core earnings per share growth at Constant Exchange Rates in 2025 (Core EPS 19.46 CHF - diluted)

39 million

patients were treated with Roche medicines in 2025

31 billion

Roche Diagnostic tests were delivered to customers worldwide in 2025

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Portrait of Thomas Schinecker

Dr Thomas Schinecker

CEO Roche Group

Roche’s Annual Report 2025

Discover how we're revolutionalising patient care in our 2025 Annual Report. Focused on innovation, research, sustainability, and strategic partnerships, with insights into our groundbreaking approaches.

Learn more

Microscopic image showing glowing blue cells clustered amidst intricate golden brown network, emitting a vibrant and scientific atmosphere.

Media contacts

Do you need to get in touch with us? Reach out to our media team with your enquiries.

In the spotlight

See all stories